Provided by Tiger Fintech (Singapore) Pte. Ltd.

TELA Bio, Inc.

2.34
-0.0100-0.43%
Volume:126.46K
Turnover:300.07K
Market Cap:92.17M
PE:-1.39
High:2.42
Open:2.36
Low:2.32
Close:2.35
Loading ...

Company Profile

Company Name:
TELA Bio, Inc.
Exchange:
NASDAQ
Establishment Date:
2012
Employees:
227
Office Location:
1 Great Valley Parkway,Suite 24,Malvern,Pennsylvania,United States
Zip Code:
19355
Fax:
- -
Introduction:
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Directors

Name
Position
Antony Koblish
President and Chief Executive Officer and Director
Kurt Azarbarzin
Chairman of the Board of Director
Adele Oliva
Director
Ashley Friedman
Director
Federica O'Brien
Director
Matt Zuga
Director
Ronald Ellis
Director
Vince Burgess
Director

Shareholders

Name
Position
Antony Koblish
President and Chief Executive Officer and Director
Nora Brennan
Chief Financial Officer
E. Skott Greenhalgh
Chief Technology Officer
Maarten Persenaire
Chief Medical Officer